Johnson & Johnson said on Wednesday its experimental psoriasis drug has shown superior skin clearance compared to Bristol Myers Squibb's Sotyktu in two late-stage head-to-head trials. ...

摩根大通将强生的目标价从185美元上调至200美元，维持"中性"评级。(格隆汇) ...

Key TakeawaysDrugmakers have collectively pledged over $350 billion in U.S. investments, with Eli Lilly and Company (LLY) leading with a $5 billion manufacturing plant in Virginia, in response to potential tariff threats.Mitsubishi Corporation (8058.T) and its partners, Anglo American (AAL) and Codelco, finalized a joint mine plan for Chilean copper operations, projecting a $5 billion pre-tax value uplift and an additional 120,000 tonnes of copper production annually.Asia-Pacific stock markets opened lower, ...

市场预期与宏观环境 - 市场预期美联储将在9月降息25个基点 推动股市上涨 并可能对企业盈利产生积极影响 [1] - 降息可能推高通胀 使利率维持在美联储2%的目标利率之上 同时地缘政治事件升级 [2] - 央行持续购买黄金 投机投资者增持比特币等加密货币 反映对宏观环境的避险需求 [2] 可口可乐公司投资亮点 - 公司股价2025年上涨6.37% 虽低于标普500指数13%的涨幅 但考虑3.03%股息收益率后总回报具竞争力 [3] - 在消费品行业整体承压背景下 公司通过拓展运动饮料、茶饮和功能水等品类实现收入与盈利增长 [4] - 分析师认为降息环境有助于公司维持或上调全年业绩指引 共识目标价76.93美元高于52周均价 [5] - 瑞银集团9月11日给予80美元目标价 较共识价仍有近5%上行空间 [5] - 公司股息收益率达3.07% 年股息2.04美元 拥有连续64年增加股息记录 派息率为72.34% [3] 强生公司转型进展 - 公司剥离消费者健康业务后 专注于制药和医疗技术领域 运营更精简高效 [7][8] - 制药管线聚焦肿瘤学和免疫疗法 医疗技术业务通过战略收购提升竞争力 [8] - 2025年股价上涨约22% 受益于资金从科技板块轮动 前瞻市盈率约16倍低于历史均值 [9] - 股息收益率2.95% 年股息5.20美元 连续64年增加股息 派息率为55.61% [6][9] 普洛斯REIT投资价值 - 作为全球最大工业房地产投资信托 专注于物流和仓储地产 occupancy率随消费信心改善而稳定 [10][11] - 积极布局可持续能源存储、数据中心开发和企业运营服务等前瞻性领域 [11] - 长期租赁合约和强劲租户需求提供稳定现金流 股息收益率达3.56% 年股息4.04美元 [10][12] - 股票交易于19倍市盈率 低于历史平均水平 具物流需求驱动的增长潜力 [12] - 尽管有连续12年增息记录 但派息率高达109.49% 需关注现金流覆盖能力 [10]

Johnson & Johnson (NYSE:JNJ) is one of the 10 Unrivaled Stocks of the Next 3 Years. On September 3, Wolfe Research increased the price target for Johnson & Johnson (NYSE:JNJ) from $175 to $195 and kept an Outperform rating. Wolfe Research cited growing confidence in Johnson & Johnson’s (NYSE:JNJ) upcoming talc litigation outcome. This confidence led the firm to use lower weighted average cost of capital (WACC) assumptions in its discounted cash flow analysis. Wolfe Research Lifts PT for Johnson & Johnson ...

>> Interesting stuff. Angelica. Thank you.We will be watching that and watching shares of those companies and those commercials. Very catchy. Well, speaking of healthcare, J&J is on your radar today for the best stocks in the market.Josh. >> Yes, I almost said with Jardiance it's easy to say I'm lowering my a-1c, but I didn't want to get CNBC in trouble. I don't know if they're a sponsor.All right J&J. Okay. This is a this is a great setup for me to explain a really important concept that transcends the J&J ...

Jade (L) and Jackie (R) Kawamoto broke through for their first Pro Women's doubles title.PPA TourThis past weekend, the Professional Pickleball Association (PPA) held its third Grand Slam event of the 2025 season, the Veolia Cincinnati Showcase, held on the grounds of the newly remodeled and upgraded Lindner Family Tennis Center (host of the WTA/ATP Masters 1000 tennis events) in the northern suburbs of Cincinnati. This event slowly got upgraded from an Open to a Cup to a Slam over the course of the year, b ...

公司业务与产品 - 公司为美国跨国制药、生物技术和医疗技术企业 业务高度多元化 制药部门拥有广泛药物产品线 [2] - 关键增长驱动包括癌症治疗药物Darzalex和Erleada 以及用于免疫学疾病的Remicade [2] - 今年新获批重症肌无力治疗药物Imaavy 膀胱癌研究性治疗药物TAR-200正在等待监管反馈 [2] - 在医疗设备领域占据重要地位 机器人辅助手术系统Ottava处于美国临床试验阶段 代表长期增长机会 [3] 股息表现 - 公司被列为13支最佳持续股息股票之一 [1] - 作为股息之王 连续63年实现股息增长 [3] - 当前季度股息为每股1.30美元 截至9月12日股息收益率为2.92% [3] 投资地位 - 被退休投资组合列为10支最佳股息股票之一 [5] - 同时入选当前值得投资的10支强力买入股息股票名单 [5]

Shanghai Henlius Biotech (OTCPK:SGBCF) is in talks with pharmaceutical giants such as Johnson & Johnson (JNJ) and Roche Holding AG (OTCQX:RHHBY) about selling them the rights to an experimental cancer drug, Bloomberg News reported early on Tuesday. The agreement could ...

Accessibility StatementSkip Navigation 21 abstracts from across the Company's portfolio highlight clinical and real-world data on major depressive disorder, treatment-resistant depression and schizophrenia New Phase 3 data demonstrate the safety and efficacy of adjunctive seltorexant compared to quetiapine XR in major depressive disorder with insomnia symptoms TITUSVILLE, N.J., Sept. 15, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today that 21 abstracts featuring new real-world and clinica ...